What Are China’s Pharmacovigilance Practices For Standardization?

China, which joined the International Council for Harmonisation (ICH) in 2017 and continues to follow its regulations, helps industry standardize its programs and practices.

Effective monitoring programs have recently been developed. They use real world data to identify, assess, and control the risks of healthcare commodities.

Pharmacovigilance plays a vital role in real-world safety data.

Increasing the significance of the Individual Case Safety Report (ICSR) and the Drug Safety Update Report (DSUR) are new risk control standards to protect the safety of patients in clinical trials.

Although Risk Management Plans (RMPs) are relatively new in China, they are an essential component of the whole product life cycle; as they are part of the overall risk management framework and strategy.

Investigational New Drug (IND) application procedures and requirements must include providing RMP’s and pharmacovigilance system documents.

3 Key Points:

1.Data obtained on a drug during clinical trials was produced under strictly controlled clinical circumstances.

2.In September 2018, the CDE released its RMP requirements to be submitted as part of the New Drug Application (NDA) package.

3.With China now a member of ICH, labeling is one of the most critical risk minimization measures for patient safety in China.

“Market globalization will inevitably bring about regulatory globalization. This includes the conduct of safety monitoring and pharmacovigilance in China.” by Jessie Zhu, Head, Drug Safety Team of Deltamed Co., Ltd.

Article Source: http://bit.ly/3aOZ3U3
Image Source: http://bit.ly/3aJUZo6

#ClinicalTrial, #ElectronicDataCapture, #ClinicalDataManagement, #ClinicalDataStrategy, #ClinicalData, #Pharmacovigilance

P.S. Stay up-to-date with what’s new in Clinical Trials! Get the latest articles summarized and delivered free to your e-mail inbox. Click here to learn more.

 

 

Latest news

Clinical_trials

Will Vivli Launch a Portal For Data Sharing of COVID-19 Trials?

Read more
Medicine doctor working with modern computer

Are Pharmaceutical Operations at Risk due to the Coronavirus?

Read more
ACTide by Nubilaria against COVID-19

“Modelling Study for the Impact of Physical Distancing on COVID-19 in...

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems